News Autifony swings $770.5m deal with Jazz for CNS drugs UK biotech Autifony has signed an exclusive licensing deal with Jazz Pharmaceuticals, giving the Ireland-headquartered drugmaker global rights to a pair of ion channel tar
News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros